![](/sites/g/files/knoqqb89996/themes/site/client_site_202/dist/images/Coherus_Investors_Header_Image.jpg)
Release Details
Coherus BioSciences Management to Present at the 41st Annual J.P. Morgan Healthcare Conference
About Coherus
Coherus is a commercial-stage biopharmaceutical company focused on the research, development, and commercialization of innovative immunotherapies to treat cancer and the commercialization of our portfolio of FDA-approved therapeutics.
Coherus Contact Information:
SVP Investor Relations
IR@coherus.com
![](https://ml.globenewswire.com/media/MTE1OGQ3NjAtNDQ3YS00YTBjLWEwODMtMDE4ZjMyYzU2Yjk2LTEwMjI3MzE=/tiny/Coherus-BioSciences-Inc-.png)
Source: Coherus BioSciences, Inc.